Fundraising FoxCapricorn Venture Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
DMC Biotechnologies is a U.S.-based biomanufacturer that uses precision fermentation and its Dynamic Metabolic Control platform to produce bio-based specialty chemicals and ingredients, such as L-alanine and fermented inositols.
BiotechClimate TechNew MaterialsBoulder, US
Matthew Lipscomb(Director)Josh Yelen(Executive Officer)Jim Flatt(Executive Officer, Director)in
BoardJosko Bobanovic(Director)Alastair Cooper(Director)
Board seatRob van der Meij· per SEC Form D · $2.5M raise · filed Dec 2025
Co-investorsBreakthrough Energy VenturesCIBUS ENTERPRISE FUND II LPSofinnova PartnersBoulder VenturesMichelin Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.